Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

GPCR

Structure Therapeutics Inc ADR

Jul 26 • 04:00PM ET

38.65

Dollar change +0.34
Percentage change 0.89	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: IBB OZEM LRNZ FDG ONEQ EWX FMED BIB GXC TMSL

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.31	Insider Own	8.36%	Shs Outstand	57.05M	Perf Week	3.23%
Market Cap	2.20B	Forward P/E	-	EPS next Y	-0.71	Insider Trans	0.00%	Shs Float	52.28M	Perf Month	2.03%
Income	-97.56M	PEG	-	EPS next Q	-0.23	Inst Own	70.34%	Short Float	21.26%	Perf Quarter	-0.85%
Sales	0.00M	P/S	-	EPS this Y	-12.35%	Inst Trans	-	Short Ratio	9.42	Perf Half Y	-8.30%
Book/sh	9.22	P/B	4.19	EPS next Y	22.45%	ROA	-27.69%	Short Interest	11.11M	Perf Year	8.97%
Cash/sh	7.65	P/C	5.05	EPS next 5Y	-	ROE	-29.29%	52W Range	25.57 - 75.02	Perf YTD	-5.18%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-22.51%	52W High	-48.48%	Beta	-3.48
Dividend TTM	-	Quick Ratio	19.05	Sales past 5Y	0.00%	Gross Margin	-	52W Low	51.15%	ATR (14)	2.98
Dividend Ex-Date	-	Current Ratio	19.05	EPS Y/Y TTM	-	Oper. Margin	0.00%	RSI (14)	45.49	Volatility	5.31% 6.83%
Employees	93	Debt/Eq	0.01	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	83.10
Option/Short	Yes / Yes	LT Debt/Eq	0.01	EPS Q/Q	25.68%	Payout	-	Rel Volume	0.49	Prev Close	38.31
Sales Surprise	-	EPS Surprise	0.72%	Sales Q/Q	-	Earnings	May 09 AMC	Avg Volume	1.18M	Price	38.65
SMA20	-1.83%	SMA50	-7.65%	SMA200	-15.96%	Trades		Volume	575,161	Change	0.89%

Date	Action	Analyst	Rating Change	Price Target Change
May-21-24	Initiated	JP Morgan	Overweight	$65
Apr-09-24	Initiated	Cantor Fitzgerald	Overweight	$65
Oct-19-23	Initiated	JMP Securities	Mkt Outperform	$90
Jul-27-23	Initiated	Piper Sandler	Overweight	$58
May-25-23	Resumed	Jefferies	Buy	$34 → $41
Feb-28-23	Initiated	SVB Securities	Outperform	$33
Feb-28-23	Initiated	Jefferies	Buy	$34
Feb-28-23	Initiated	Guggenheim	Buy	$50
Feb-28-23	Initiated	BMO Capital Markets	Outperform	$40

Jul-24-24 08:55AM	What's in Store for Structure Therapeutics (GPCR) in Q2 Earnings? (Zacks)
Jul-17-24 10:47AM	Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics? (Benzinga) -14.15%
Jul-12-24 06:08AM	The 3 Most Undervalued Biotech Stocks to Buy in July 2024 (InvestorPlace)
Jun-28-24 10:09AM	The 3 Smartest Biotech Stocks to Buy With $5K Right Now (InvestorPlace)
Jun-17-24 09:53AM	Could Structure Therapeutics Become the Next Novo Nordisk? (Motley Fool)
07:31PM	Loading…
Jun-11-24 07:31PM	Structure Therapeutics CEO on GLP drugs (CNBC TV) -5.42%
09:59AM	Structure Therapeutics (GPCR) Rallying on Obesity Drug Data (Zacks)
04:57AM	Structure Therapeutics Stock Could Rocket 87% Higher, According to 1 Wall Street Analyst. Is It Time to Buy? (Motley Fool)
Jun-09-24 07:30AM	Structure Therapeutics' Stock Is Soaring on the Promise of Its Wegovy Competitor, but Is It a Buy? (Motley Fool)
Jun-07-24 04:05PM	Structure Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional American Depositary Shares (GlobeNewswire)
05:00AM	Ozempic competitors, psychedelic stocks, and Moderna after COVID: Pharma news roundup (Quartz)
Jun-05-24 07:53PM	Structure Therapeutics Announces Pricing of Upsized $476 Million Public Offering (GlobeNewswire)
Jun-04-24 11:59AM	Qiming's Nisa Leung Made the 2024 Forbes Midas List (PR Newswire)
06:00AM	The 3 Most Undervalued Biotech Stocks to Buy in June 2024 (InvestorPlace)
02:03AM	Heard on the Street Monday Recap: Catnip (The Wall Street Journal)
06:55PM	Loading…
Jun-03-24 06:55PM	Structure Therapeutics is a 'no-brainer takeout' target, says Mizuho's Jared Holz (CNBC TV) +54.21%
04:09PM	Structure Therapeutics Announces Proposed Public Offering of American Depositary Shares and Pre-Funded Warrants (GlobeNewswire)
03:30PM	Structure Therapeutics (GPCR) Stock Soars 60% on Weight Loss Drug Success (InvestorPlace)
01:42PM	Structure Therapeutics Stock Skyrockets To Six-Month High On Compelling Weight-Loss Drug Results (Investor's Business Daily)
01:17PM	The race for a weight loss pill heats up as a Novo Nordisk competitor releases new trial results (Quartz)
12:30PM	Heard on the Street: Wall Street Is Cheering a New Obesity Pill Candidate. Here's Why. (The Wall Street Journal)
11:30AM	Structure Therapeutics Stock Soars on Obesity Pill Data (The Wall Street Journal)
08:20AM	Structure pill leads to competitive weight loss in obesity study (BioPharma Dive)
07:30AM	Structure Therapeutics Reports Positive Topline Data from its Phase 2a Obesity Study and Capsule to Tablet PK Study for its Oral Non-Peptide Small Molecule GLP-1 Receptor Agonist GSBR-1290 (GlobeNewswire)
Jun-02-24 09:07AM	J.P. Morgan Predicts up to 210% Gains for These 2 Strong Buy Stocks (TipRanks)
May-31-24 06:00AM	Unearthing Unknown Stocks: 3 Picks That Could Be the Next Big Thing (InvestorPlace)
May-21-24 07:44AM	JPMorgan Starts Structure Therapeutics With Overweight Rating (MT Newswires)
May-09-24 10:56PM	GPCR Stock Earnings: Structure Therapeutics Beats EPS for Q1 2024 (InvestorPlace) -7.32%
04:05PM	Structure Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights (GlobeNewswire)
10:34AM	7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025 (InvestorPlace)
06:33AM	Loading…
Apr-24-24 06:33AM	3 Speculative Weight Loss Drug Stocks to Bet On for Big Gains (InvestorPlace)
Mar-30-24 09:37AM	7 Small-Cap Stocks that Wall Street Loves for Good Reason (InvestorPlace)
Mar-15-24 10:53AM	GPCR Stock Earnings: Structure Therapeutics Beats EPS for Q4 2023 (InvestorPlace)
Mar-08-24 04:05PM	Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference (GlobeNewswire)
08:30AM	Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Highlights (GlobeNewswire)
Jan-22-24 05:24AM	Here's Why Structure Therapeutics (GPCR) Fell in Q4 (Insider Monkey)
Dec-25-23 07:45AM	Structure Therapeutics Stock Just Crashed. Here's Why It Could Be Worth Buying Now (Motley Fool)
Dec-22-23 04:21PM	7 Small-Cap Stocks That Wall Street Loves for Good Reason (InvestorPlace) +7.85%
Dec-18-23 04:06PM	Structure Plummets 43% After Trailing Lilly In Obesity Treatment (Investor's Business Daily) -42.82% +10.05%
01:03PM	Another Drugmaker Hits Rocks Seeking a Weight-Loss Pill (The Wall Street Journal)
11:29AM	New Shakeup Hits Obesity Pills. Structure Rolls Out Disappointing Data. (Barrons.com)
09:22AM	Structure Stock Takes A Brutal Beating After Obesity Drug Trails Lilly's Leader (Investor's Business Daily)
07:30AM	Structure Therapeutics Provides Comprehensive GSBR-1290 Program Update Including Clinically Meaningful Proof-of-Concept Data From Phase 2a Clinical Study (GlobeNewswire)
07:30AM	Structure Therapeutic obesity pill shows promise in mid-stage trial (Reuters)
06:23AM	Structure shares sink as obesity pill misses expectations in small study (BioPharma Dive)
Dec-11-23 12:26PM	3 Biotech Stocks to Turn $5,000 Into $1 Million: December 2023 (InvestorPlace)
Nov-29-23 02:28PM	If You Can Only Buy One Biotech Stock in December, It Better Be One of These 3 Names (InvestorPlace)
02:30AM	11 Best Young Stocks to Buy and Hold For 20 Years (Insider Monkey)
Nov-27-23 09:50AM	11 Best Upside Stocks To Buy Right Now (Insider Monkey)
Nov-26-23 04:44PM	2 Biotech Stocks That Could Soar in December (Motley Fool)
Nov-14-23 04:10PM	Structure Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights (GlobeNewswire) -9.83%
Nov-03-23 05:20AM	Should You Still Buy the Nasdaq's Best-Performing October Stocks? (Motley Fool)
Oct-19-23 08:45AM	Melanocortin Receptor R&D to Target Increasing Prevalence of Obesity-Related Disorders (PR Newswire)
Oct-06-23 08:45AM	Structure Therapeutics (GPCR) Stock Up 9% This Week: Here's Why (Zacks)
Oct-02-23 03:48PM	Why Shares of Structure Therapeutics Are Up Monday (Motley Fool) +12.26%
Sep-29-23 04:04PM	Structure Soars 35% As Newcomer Takes On Behemoths Lilly, Novo In Obesity Treatment (Investor's Business Daily) +34.56%
12:50PM	Why Shares of Structure Therapeutics Are Soaring on Friday (Motley Fool)
11:19AM	Structure Stock Soars. Its Obesity Pill Could Challenge Lilly, Novo. (Barrons.com)
10:24AM	Upstart Weight-Loss Drugmaker Jumps 75% on Strong Test Results (Bloomberg)
09:34AM	Newcomer Structure Throws Down The Gauntlet In Obesity Treatment -- Shares Soar 66% (Investor's Business Daily)
07:32AM	Structure Therapeutics Announces $300 Million Private Placement Equity Financing (GlobeNewswire)
07:30AM	Structure Therapeutics Announces Positive Results from Phase 1b Clinical Study of Oral GLP-1 Receptor Agonist GSBR-1290 and Provides Program Update (GlobeNewswire)
Aug-10-23 04:05PM	Structure Therapeutics Reports Second Quarter 2023 Financial Results and Recent Highlights (GlobeNewswire) -6.06%
Aug-03-23 05:32PM	Structure Therapeutics Appoints Ted W. Love, M.D., to Board of Directors (GlobeNewswire) -7.79%
Jul-16-23 07:00AM	Drugs Like Ozempic Created a Gold Rush. These Drugmakers Want In. (The Wall Street Journal)
Jun-27-23 02:10PM	Eli Lilly, Pfizer, and Others Are Working on Weight-Loss Pills. What to Know. (Barrons.com) +8.16%
01:35PM	Lilly, Pfizer and Others Are Working on Obesity Pills. What to Know. (Barrons.com)
08:12AM	Pfizer Makes a Call on Obesity Pill. Investors Arent Happy. (Barrons.com)
Jun-26-23 09:05PM	Why Shares of Structure Therapeutics Rose Monday (Motley Fool) +18.35%
Jun-16-23 08:00AM	This Biotech Is Developing The Next Ozempic. Should You Buy It? (Motley Fool)
Jun-13-23 06:10AM	Institutional investors own a significant stake of 45% in Structure Therapeutics Inc. (NASDAQ:GPCR) (Simply Wall St.)
Jun-12-23 10:15AM	Buying Shares of These 2 Biotech Stocks Could Be a Brilliant Move in 5 Years (Motley Fool)
Jun-07-23 08:30AM	Structure Therapeutics Announces Poster Presentations of its Oral GLP-1 Receptor Agonist GSBR-1290 at the American Diabetes Association 83rd Scientific Sessions (GlobeNewswire)
May-31-23 04:30PM	Structure Therapeutics to Present at Jefferies Healthcare Conference (GlobeNewswire)
May-25-23 04:30PM	Structure Therapeutics Initiates Phase 2a Study of Oral GLP-1 agonist GSBR-1290 for the Treatment of Type 2 Diabetes and Obesity (GlobeNewswire) +7.94% +9.97%
May-18-23 04:30PM	Structure Therapeutics Announces Poster Presentations at the American Thoracic Society International Conference (GlobeNewswire) +7.64%
May-11-23 04:30PM	Structure Therapeutics Reports First Quarter 2023 Financial Results and Recent Highlights (GlobeNewswire) +5.60%
May-03-23 06:59AM	Companies Like Structure Therapeutics (NASDAQ:GPCR) Are In A Position To Invest In Growth (Simply Wall St.)
Mar-30-23 04:30PM	Structure Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights (GlobeNewswire) +7.65%
Feb-07-23 04:00PM	Structure Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters Option to Purchase Additional American Depositary Shares (GlobeNewswire)
Feb-06-23 03:17PM	The Funded: A solar industry company is on deck to complete the 1st major Bay Area tech IPO in more than a year (American City Business Journals)

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. The company was founded by Raymond Stevens in February 2019 and is headquartered in South San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Stevens Raymond C	CHIEF EXECUTIVE OFFICER	Jun 12 '24	Option Exercise	0.42	150,000	63,000	793,346	Jun 14 08:19 PM
Lin Xichen	CHIEF SCIENTIFIC OFFICER	Jun 03 '24	Option Exercise	0.34	106,200	36,108	191,907	Jun 05 07:38 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GPCR

Structure Therapeutics Inc ADR

Upgrade your FINVIZ experience